Navigation Links
Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
Date:9/13/2012

s of our development program, we are pleased to have the ongoing support of the U.S. Government to evaluate not only IV administration but also the more rapid, cost-effective IM administration of ETI-204," said Elizabeth Posillico, PhD, President and Chief Executive Officer of Elusys. "Advancing the development of both IV and IM administration of our anti-toxin could provide two important options in the prevention and treatment of inhalational anthrax following a biowarfare attack."

Elusys continues to work closely with the U.S. Food and Drug Administration (FDA) on the design of the ETI-204 Phase 3 development program in preparation for an anticipated End of Phase 2 meeting. ETI-204 was granted Fast Track status and Orphan Drug Designation in 2006 by the FDA.

About ETI-204

ETI-204 is a high-affinity, humanized and deimmunized monoclonal antibody that targets the protective antigen of B. anthracis and neutralizes the lethal effects of anthrax toxins by binding to Protective Antigen.  It is an investigational agent being developed for treatment of inhalational anthrax following a biowarfare attack.

ETI-204 efficacy and safety are being studied in animals and safety studies are being conducted with human volunteers. To date, five studies assessing the efficacy and safety of ETI-204 in animals with inhalational anthrax have been completed, and three studies assessing pharmacokinetics and safety of IV administration of ETI-204 in humans have been conducted. In the two completed studies, the adverse event profile of ETI-204 was comparable to placebo and the more common adverse events related to ETI-204 administration were headache and upper respiratory tract infection. ETI-204 is formulated as a solution suitable for either IV or IM administration. This program is supported with federal funds from the Office of the Assistant
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
2. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
3. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
4. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
5. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
6. Turner Construction Company Awarded Fort Irwin Replacement Hospital
7. Spot On Sciences Awarded $1 Million DARPA Grant to Develop a Blood Sample Collection Device
8. Texas A&M System Awarded National Center for Innovation
9. Sorrento Therapeutics Awarded Third Phase I STTR Grant
10. SurgiCount Medical Awarded Contract From HealthTrust Purchasing Group for the Safety-Sponge® System
11. New Chronic Wound Therapy Awarded at Texas Largest Life Science Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  New York College of Health Professions announces ... portfolio with U.S. Patent #8,996,098 donated by its Chairman ... a surgical instrument that allows surgeons to view and ... in the traditional format of a slide that is ... during surgery, thus providing the surgeon real time analysis ...
(Date:4/1/2015)... ASPEN, Colo. , April 1, 2015  Astellas ... (CKF), is pleased to sponsor the second annual Bounce ... award, which will recognize two transplant recipients who exhibit ... a career accomplishment, participation in a sport or hobby, ... loved ones. "The Bounce Back Award ...
(Date:4/1/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceutical Industries ("Teva") is being investigated by WeissLaw LLP, ... investigation focuses on possible breaches of fiduciary duty and ... of ASPX for agreeing to sell the Company to ... definitive agreement for Teva to acquire ASPX in a ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... Recent Highlights: Qutenza ® (capsaicin) ... adoption by large US institutions; 238 hospitals purchased as of 4Q10, ... Q4 2010 revenue totaled $2.3 million including $0.5 million U.S. Qutenza ... in 17 countries at December 31, 2010 NGX-1998 Phase 2 ...
... March 30, 2011 Rochester Medical Corporation (Nasdaq: ... BioSciences N.V. today approved the previously announced sale of ... subsidiary to Rochester Medical Corporation. Rochester Medical ... and under the terms of the Share Purchase Agreement ...
Cached Medicine Technology:NeurogesX Reports Fourth Quarter and Year-End 2010 Results 2NeurogesX Reports Fourth Quarter and Year-End 2010 Results 3NeurogesX Reports Fourth Quarter and Year-End 2010 Results 4NeurogesX Reports Fourth Quarter and Year-End 2010 Results 5NeurogesX Reports Fourth Quarter and Year-End 2010 Results 6NeurogesX Reports Fourth Quarter and Year-End 2010 Results 7NeurogesX Reports Fourth Quarter and Year-End 2010 Results 8NeurogesX Reports Fourth Quarter and Year-End 2010 Results 9Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation 2
(Date:4/1/2015)... ON (PRWEB) April 01, 2015 It all ... founder Patricia Di Gasbarro, who was on a mission to ... pure and simple ingredients that parents could trust. Now, Shoosha ... Food Grade Organic skincare products, meaning all products contain a ... North America. , Babies’ skin is considered to be 40% ...
(Date:4/1/2015)... SCI Solutions , the health ... announced that CEO Joel French will be a featured ... Exhibition in Chicago, April 12-16, 2015. French will ... Care Coordination Strategies ” with Northeast Georgia Health System ... More than 38,000 healthcare industry professionals are expected at ...
(Date:4/1/2015)... San Diego, CA (PRWEB) April 01, 2015 ... promotion organization, is announcing two continuing medical education ... goal is to help practitioners become more confident ... to prevent disease. After completion of these CME ... , The CME courses available are ...
(Date:4/1/2015)... 01, 2015 Like a mosaic slowly ... scientific understanding of the potential causes of rosacea. April ... National Rosacea Society (NRS) to educate the public on ... disorder now estimated to affect more than 16 million ... research on rosacea through its patient-funded research grants program, ...
(Date:4/1/2015)... April 01, 2015 Health Advocate™, Inc., ... a subsidiary of West Corporation, today launched its new ... http://blog.healthadvocate.com and through the Health Advocate member website, ... get, and stay, healthy. , “We’re pleased to introduce ... the public,” said Martin Rosen, Executive Vice President, Health ...
Breaking Medicine News(10 mins):Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:Health Advocate Launches New Health and Wellness Blog 2
... 2009 -- Children regularly exposed to tobacco smoke at ... adulthood. This finding by researchers at Columbia University,s Mailman ... not recover completely from the effects of early-life exposures ... the December 2009 American Journal of Epidemiology . ...
... ... one percent of the risk of electronic cigarettes and that attacks on them are due ... ... Professor Carl Phillips, associate professor at the University of Alberta, has argued that electronic cigarettes ...
... ... American children overweight and obese, Smart for Life,s new THIN ADVENTURE(TM) ... for children between the ages of 6 and 14. It will be ... , The program was designed by Dr. Sasson Moulavi ( Dr. Sass ...
... , , Site recognized as Best Online Health ... , WESTPORT, Conn. , Dec. 28 dLife, the ... to its Web site dlife.com reached an all time high with ... in which dlife.com metrics rose 35%+ versus 2008 in visits and ...
... effectiveness, but many don,t, study finds , MONDAY, Dec. 28 ... don,t return for follow-up tests that make sure the procedure ... go back, and therefore risk an unwanted pregnancy, are more ... of four or more children, the study found. , The ...
... ... Hailed by best selling authors such as Jack Canfield, Dr. Joe ... after fitness guru to date, who entertains, educates and enlightens audiences worldwide ... Nicole Lee (JNL) is a weight loss success story who has become ...
Cached Medicine News:Health News:Exposure to tobacco smoke in childhood home associated with early emphysema in adulthood 2Health News:Professor: No Doubt Electronic Cigarettes Safer than Cigarettes 2Health News:THIN ADVENTURE(TM) Presents the First Children's Do-It-Yourself Weight-Loss Program 2Health News:THIN ADVENTURE(TM) Presents the First Children's Do-It-Yourself Weight-Loss Program 3Health News:THIN ADVENTURE(TM) Presents the First Children's Do-It-Yourself Weight-Loss Program 4Health News:dLife.com Hits 1 Million Plus Visitors! 2Health News:Half of Men Fail to Check if Vasectomy is Working 2Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 2Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 3Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 4
... safely provides effective air warming therapy to ... design of our WarmAir® FilteredFlo® blankets, we ... supplies gently moving, clean air that minimizes ... to your patient or staff. All air ...
Since 1964, in its plants of Sesto Fiorentino, Sbisà produces a wide and qualified range of instruments for ophthalmology and optometry....
Inquire...
Inquire...
Medicine Products: